The latest issue of Financial Standard now available as an e-newspaper

READ NOW

Search Results

Showing 231 - 238 of 238 results for "Pharmaceutical"

Free trade deal goes public, but attacked over PBS

AAP | FRIDAY, 5 MAR 2004

... Officials were unable to explain a key detail in the agreement which will allow decisions to exclude drugs from the Pharmaceutical Benefits Scheme to be reviewed. But the government and the man who led the negotiations, Stephen Deady, said the deal was ...

US and Australia sign free trade agreement

The United States and Australia have signed a trade agreement that officials say will eliminate duties from more than 99 per cent of American manufacturing exports to Australia. US Trade Representative Robert Zoellick described the deal, which requires ...

FTA opponents to urge protection of health/culture

AAP | THURSDAY, 15 JAN 2004

... from 63 organisations and more than 2,000 individuals to Trade Minister Mark Vaile urging the protection of the Pharmaceutical Benefits Scheme and Australian content rules for film and television. It comes as trade officials prepare to head for the US ...

Midday market wrap: Shares, bonds both ease on stronger US data

The Australian share market opened in negative territory, following a fall in the United States market on Friday night. At early trade the benchmark S&P/ASX 200 index was 9.3 points weaker at 3239.2 while the all ordinaries index fell 7.6 points to ...

Healthcare expenditure at record highs: OECD

... during the past decade. This figure on average represents 8.4% of GDP. With regard to Australia, OECD said that pharmaceutical spending rose by more than 70% in real terms between 1990 and 2001. The report also revealed less than 20% of Australian adults ...

ABS releases third survey on venture capital trends

The Australian Bureau of Statistics (ABS) today released the results of its third venture capital survey, indicating further strong growth occurring during 2001-02. The ABS said that as at June 30 2002, investors had $6.9 billion committed to venture ...

BankWest acquires API Finance

Australian Pharmaceutical Industries Limited (API) and BankWest have announced a broad ranging alliance that includes the acquisition by BankWest of finance subsidiary API Finance with its $300 million loan and lease book and the development of an expanded ...

March quarter records highest price rises since 1995: ABS

The Australian Bureau of Statistics (ABS) today announced that the Consumer Price Index (CPI) had risen by 1.3 per cent for the March quarter 2003, up from 0.7% in the December quarter 2002. The ABS said that apart from the September quarter 2000, which ...

PAGE:

Federal Court calls out ASIC for re-running case on appeal

RIDDHIMA TALWANI | 12:39PM

The Full Federal Court of Australia has criticised regulators for falling back on appeals to re-litigate cases on a different legal basis than the one run at trial.

Evergreen founder exits Ascalon Capital

KARREN VERGARA | 12:33PM

Ascalon Capital has bid farewell to Evergreen Consultants' founder Angela Ashton, shortly after acquiring the consulting firm last year.

Powerhouse Ventures partners with European fund manager

KARREN VERGARA | 12:10PM

ASX-listed Powerhouse Ventures has partnered with an unnamed European fund manager that will commit US$50 million to its fledgling Critical Infrastructure Opportunities (CIO) Fund.

KeyInvest unveils new investment platform, awards mandate

MATTHEW WAI | 12:28PM

KeyInvest has launched a new investment platform to include a plethora of investment strategies ranging from private credit to global equities.

Videos

Brought to you by

The market has changed. The opportunity hasn't.

Follow the leaders

Global economic outlook and the case for local currency emerging market debt: Resilience, risk, and opportunity

Maintaining a fundamental focus in a world obsessed with the short term

Strength amid noise

SMILE through retirement - tackling the top 5 (Sequencing, Market, Inflation, Longevity, Emotion) retirements risks

A guaranteed future

MORE VIDEOS

Products

'Guide To' Series

Pocket investment guides featuring adviser case studies and a glossary.

MORE INFO

Publisher's Forum

Investing trends and strategies from the industry’s thought leaders.

MORE INFO

Product Showcases

Putting the spotlight on investment products that matter.

MORE INFO

Expert Feed

Christian Mueller-Glissmann

Head of Asset Allocation Research

Goldman Sachs

When geopolitics becomes a portfolio risk

Geopolitics is back - again - and Australian investors can no longer treat it as distant background noise.

READ MORE

Tania Milnes

General Manager Membership

Financial Advice Association Australia

Does association membership still matter?

With all the changes the advice sector has experienced in recent years, such as regulatory reform and increased education and professional standards ...

READ MORE

Effie Dimitropoulos

Chief executive

AUDD

Digital assets and where they stand in 2026

So far in 2026 digital assets have captured the headlines largely for the wrong reasons, but that doesn't tell the full story.

READ MORE

Jessica Sclafani

Global retirement strategist

T. Rowe Price

Rethinking default design in a changing market environment

The evolution underway in the US DC system highlights the value of periodically reassessing default design assumptions.

READ MORE

Industry Events

MORE INDUSTRY EVENTS

JUL

Advisers Big Day Out - Hobart

Featured Profile

MORE PROFILES

Brian Redican

CHIEF ECONOMIST
NEW SOUTH WALES TREASURY CORPORATION

What makes an economist an economist? TCorp chief economist Brian Redican reflects on over three decades of navigating Australia's economic cycles. Riddhima Talwani writes.

READ MORE